mTOR Inhibitor-1>98.0%(HPLC)5mg

[(2H-1,3-benzodioxol-5-yl)methyl](propyl)amine, 95.0%, 10g

2,5-Bis(4-bromophenyl)-1,1-dimethyl-3,4-diphenyl-1H-silole, 97%, 250mg

TERT-BUTYL 8-BROMOQUINOLIN-3-YLCARBAMATE, 99.0%, 100mg

1-(TRIISOPROPYLSILYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-OL, 95.0%, 1g

3-Amino-5-methyl-hexanoic acid, 97.0%, 25g

(3-HYDROXYPIPERIDIN-1-YL)(PHENYL) METHANONE, 95.0%, 250mg

(2R)-(-)-1,1-BIS(4-METHOXYPHENYL)-3-METHYL-1,2-BUTANEDIAMINE, 95%, 5g

2,6-Bis(benzo[d]oxazol-2-yl)pyridine, 98%, 100mg

1-(2-Fluorophenyl)-2-thiourea, 97.0%, 25g

3-fluorobenzyl-triphenylphosphonium bromide, 5g

1-(3,4-dichlorobenzoyl)-2-methylpiperazine, 95.0%, 5g

6,6'-Methylenebis(2-bromo-4-chlorophenol), 98%, 5g